Very early researchNot Yet RecruitingNCT07706205
What this trial is testing
Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) as Conditioning Regimen for ABO-incompatible Living Donor Kidney Transplantation
Who this might be right for
ABO Blood Type Incompatible Kidney Transplantation
West China Hospital 20